Faron Pharmaceuticals Oy (AIM:FARN)
London · Delayed Price · Currency is GBP · Price in GBX 53.65
-4.35 (-7.50%)
Mar 5, 2026, 8:42 AM GMT
Faron Pharmaceuticals Oy Revenue
In the year 2025, Faron Pharmaceuticals Oy had annual revenue of 1.31M EUR.
Revenue
1.31M EUR
Revenue Growth
n/a
P/S Ratio
58.85
Revenue / Employee
40.88K EUR
Employees
32
Market Cap
67.15M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.31M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| hVIVO | 54.47M |
| Bioventix | 13.12M |
| Arecor Therapeutics | 5.06M |
| Scancell Holdings | 4.71M |
| SkinBioTherapeutics | 4.64M |
| 4basebio | 1.78M |
| Aptamer Group | 1.20M |
| Ondine Biomedical | 1.18M |
Faron Pharmaceuticals Oy News
- 12 hours ago - Faron Pharmaceuticals Oy (FRA:4FR) Full Year 2025 Earnings Call Highlights: Clinical Successes ... - GuruFocus
- 14 hours ago - Full Year 2025 Faron Pharmaceuticals Oy Earnings Call Transcript - GuruFocus
- 21 days ago - Faron Pharmaceuticals Oy (FPHAF) Discusses Clinical Progress and Development Plans for BEXMAB in High-Risk MDS Transcript - Seeking Alpha
- 8 months ago - Faron Pharmaceuticals To Earn Spotlight At IUIS 2025 With Its Bexmarilimab Data - IBTimes